Profile
Daniel Kaplan is currently the Chief Scientific Officer at NGM Biopharmaceuticals, Inc. He started this position in 2023.
Prior to his current role, he obtained a doctorate degree from Duke University and an undergraduate degree from the University of California San Diego.
Daniel Kaplan active positions
| Companies | Position | Start |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2023 |
Training of Daniel Kaplan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Daniel Kaplan
















